2
RESEARCH METHODOLOGY
37
5
MARKET OVERVIEW
Biochip market surges with AI integration, personalized medicine, and emerging microfluidic technologies.
62
5.2.1.1
RISING ADOPTION OF PERSONALIZED MEDICINE
5.2.1.2
TECHNOLOGICAL ADVANCEMENTS IN MICROARRAY AND MICROFLUIDICS FABRICATION
5.2.1.3
INCREASING R&D INVESTMENTS IN GENOMICS AND PROTEOMICS
5.2.1.4
ADVANCEMENTS IN POINT-OF-CARE DIAGNOSTICS AND LAB-ON-A-CHIP TECHNOLOGIES
5.2.2.1
HIGH COST OF INSTRUMENTS AND FABRICATION
5.2.2.2
COMPLEX DATA INTERPRETATION AND STANDARDIZATION
5.2.3.1
INTEGRATION OF AI AND BIOINFORMATICS IN BIOCHIP DATA ANALYSIS
5.2.3.2
EXPANSION INTO EMERGING MARKETS AND NEW APPLICATIONS
5.2.4.1
TECHNICAL COMPLEXITY AND INTEGRATION OF MULTIDISCIPLINARY TECHNOLOGIES
5.2.4.2
REGULATORY AND VALIDATION HURDLES FOR CLINICAL USE
5.3.1
MINIATURIZATION, PORTABILITY, AND DECENTRALIZED DIAGNOSTICS
5.3.2
SHIFT TOWARD MICROFLUIDICS AND LAB-ON-A-CHIP FORMATS
5.4.1.1
DIGITAL MICROFLUIDIC BIOCHIPS
5.4.1.2
PLASMONIC AND NANOPLASMONIC BIOCHIPS
5.4.1.3
WEARABLE AND IMPLANTABLE BIOCHIPS
5.4.2
ADJACENT TECHNOLOGIES
5.4.2.1
AI/MACHINE LEARNING FOR BIOCHIP DATA & DESIGN
5.4.2.2
OPTICAL GENOME MAPPING CHIPS
5.4.3
COMPLEMENTARY TECHNOLOGIES
5.4.3.1
ADVANCED MICROFABRICATION AND 3D PRINTING
5.4.3.2
BIOCHIP INTEGRATION IN BIOSENSORS
5.5
PORTER’S FIVE FORCES ANALYSIS
5.5.1
THREAT OF NEW ENTRANTS
5.5.2
THREAT OF SUBSTITUTES
5.5.3
BARGAINING POWER OF SUPPLIERS
5.5.4
BARGAINING POWER OF BUYERS
5.5.5
INTENSITY OF COMPETITIVE RIVALRY
5.6.1
REGULATORY ANALYSIS
5.6.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7.1
PATENT PUBLICATION TRENDS FOR BIOCHIPS
5.7.2
JURISDICTION AND TOP APPLICANT ANALYSIS
5.8.1
IMPORT DATA FOR HS CODE 9027
5.8.2
EXPORT DATA FOR HS CODE 9027
5.9.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.9.2
AVERAGE SELLING PRICE TREND, BY REGION
5.9.2.1
AVERAGE SELLING PRICE OF DNA CHIPS AND LAB-ON-A-CHIP, BY REGION
5.9.2.2
AVERAGE SELLING PRICE TREND OF DNA CHIPS, BY REGION
5.9.2.3
AVERAGE SELLING PRICE TREND OF LAB-ON-A-CHIP, BY REGION
5.9.2.4
AVERAGE SELLING PRICE TREND OF PROTEIN CHIPS, BY REGION
5.10
KEY CONFERENCES AND EVENTS, 2025–2026
5.11
KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.12
END-USER ANALYSIS AND UNMET NEEDS
5.13
IMPACT OF AI/GENERATIVE AI ON BIOCHIPS MARKET
5.13.2
MARKET POTENTIAL IN BIOCHIPS ECOSYSTEM
5.13.4
KEY COMPANIES IMPLEMENTING AI IN BIOCHIPS MARKET
5.15.1
MICROFLUIDIC BIOCHIP-BASED MULTIPLEXED PROFILING FOR EARLY CANCER DETECTION
5.15.2
POINT-OF-CARE TUMOR MARKER DETECTION BIOCHIP
5.15.3
GRAPHENE QUANTUM DOT-BASED BIOCHIP FOR CHILDHOOD LEUKEMIA DETECTION
5.16
VALUE CHAIN ANALYSIS
5.17
SUPPLY CHAIN ANALYSIS
5.18
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.19
INVESTMENT AND FUNDING SCENARIO
5.20
US TARIFF IMPACT ON BIOCHIPS MARKET
5.20.3
PRICE IMPACT ANALYSIS
5.20.4
IMPACT ON COUNTRY/REGION
5.20.5
IMPACT ON END-USE INDUSTRIES
5.20.5.1
BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
5.20.5.2
HOSPITALS AND DIAGNOSTIC CENTERS
5.20.5.3
ACADEMIC & RESEARCH INSTITUTES
5.20.5.4
CONTRACT RESEARCH ORGANIZATIONS (CROS)
6
BIOCHIPS MARKET, BY PRODUCTS & SERVICES
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables
109
6.2.1
SURGE IN APPLICATIONS ACROSS PERSONALIZED MEDICINE AND PRECISION DIAGNOSTICS TO AID GROWTH
6.3.1
RISING DEMAND FOR ADVANCED INSTRUMENTS TO ENHANCE PRECISION AND EFFICIENCY TO DRIVE MARKET
6.4.1
INCREASING NEED FOR ADVANCED DATA ANALYSIS AND BIOINFORMATICS TO SUPPORT GROWTH
7
BIOCHIPS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 47 Data Tables
118
7.2.1
GLOBAL VOLUME ANALYSIS OF DNA CHIPS, 2023–2030 (THOUSAND UNITS)
7.2.2
DNA CHIPS MARKET, BY APPLICATION
7.2.2.3
CANCER DIAGNOSTICS & TREATMENT
7.2.2.6
AGRICULTURAL BIOTECHNOLOGY
7.2.2.7
OTHER DNA CHIP APPLICATIONS
7.3.1
GLOBAL VOLUME ANALYSIS OF LAB-ON-A-CHIP, 2023–2030 (THOUSAND UNITS)
7.3.2
LAB-ON-A-CHIP MARKET, BY APPLICATION
7.3.2.1
CLINICAL DIAGNOSTICS
7.3.2.6
OTHER LOAC APPLICATIONS
7.4.1
GLOBAL VOLUME ANALYSIS OF PROTEIN CHIPS, 2023–2030 (THOUSAND UNITS)
7.4.2
PROTEIN CHIPS MARKET, BY APPLICATION
7.4.2.2
EXPRESSION PROFILING
7.4.2.4
HIGH-THROUGHPUT SCREENING
7.4.2.6
OTHER PROTEIN CHIP APPLICATIONS
7.5.1
INCREASING DEMAND FOR LARGE-SCALE VALIDATION OF BIOMARKERS TO SPUR GROWTH
7.5.2
GLOBAL VOLUME ANALYSIS OF TISSUE ARRAYS, 2023–2030 (THOUSAND UNITS)
7.6.1
EXPANDING USE OF CELL ARRAYS FOR HIGH-THROUGHPUT CELLULAR ANALYSIS AND DRUG SCREENING TO AID GROWTH
7.6.2
GLOBAL VOLUME ANALYSIS OF CELL ARRAYS, 2023–2030 (THOUSAND UNITS)
8
BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 5 Data Tables
171
8.2.1
WIDESPREAD ADOPTION OF MICROARRAYS IN GENOMIC AND PROTEOMIC RESEARCH TO FUEL MARKET
8.3.1
GROWING DEMAND FOR DECENTRALIZED, POINT-OF-CARE DIAGNOSTICS, AND HIGH-THROUGHPUT SCREENING TOOLS TO DRIVE MARKET
9
BIOCHIPS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
177
9.2
BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
9.2.1
RISING TREND OF PERSONALIZED AND PRECISION THERAPEUTICS TO EXPEDITE GROWTH
9.3
HOSPITALS & DIAGNOSTIC CENTERS
9.3.1
INCREASING HOSPITAL INVESTMENTS IN MOLECULAR PATHOLOGY TO EXPEDITE GROWTH
9.4
ACADEMIC & RESEARCH INSTITUTES
9.4.1
GROWING USE OF BIOCHIPS IN GENE-FUNCTION RELATIONSHIPS, PROTEIN NETWORKS, AND DISEASE MECHANISMS TO BOOST MARKET
9.5
CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.5.1
INCREASING TREND OF OUTSOURCING RESEARCH AND DEVELOPMENT ACTIVITIES TO PROMOTE GROWTH
10
BIOCHIPS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 20 Countries | 241 Data Tables.
188
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2
NORTH AMERICA: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
10.2.3.1
PRESENCE OF PROMINENT COMPANIES AND HIGH CANCER PREVALENCE TO EXPEDITE GROWTH
10.2.4.1
EXPANDING GENOMICS AND PRECISION MEDICINE INITIATIVES TO DRIVE MARKET
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2
EUROPE: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
10.3.3.1
ROBUST ECOSYSTEM OF BIOTECH STARTUPS AND MULTINATIONAL CORPORATIONS TO PROMOTE GROWTH
10.3.4.1
INCREASING HEALTHCARE INVESTMENTS AND GENOMIC ADVANCEMENTS TO DRIVE MARKET
10.3.5.1
STRONG GOVERNMENT INITIATIVES IN BIOTECHNOLOGY, PRECISION MEDICINE, AND HEALTHCARE INNOVATIONS TO BOOST MARKET
10.3.6.1
GROWING DEMAND FOR PRECISION MEDICINE TO SPUR GROWTH
10.3.7.1
INCREASING DEMAND FOR PERSONALIZED MEDICINE AND STRONG GOVERNMENTAL & INSTITUTIONAL SUPPORT TO PROPEL MARKET
10.3.8.1
INCREASING EMPHASIS ON GENOMICS AND PERSONALIZED MEDICINE TO FAVOR GROWTH
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2
ASIA PACIFIC: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
10.4.3.1
RISING HEALTHCARE DEMAND TO SUPPORT GROWTH
10.4.4.1
INCREASING GERIATRIC POPULATION TO DRIVE MARKET
10.4.5.1
STRONG GOVERNMENT SUPPORT FOR DOMESTIC BIOTECH MANUFACTURING TO FACILITATE GROWTH
10.4.6.1
INCREASING ADVANCEMENTS IN BIOTECHNOLOGY TO SPUR GROWTH
10.4.7.1
INCREASING HEALTHCARE EXPENDITURE TO EXPEDITE GROWTH
10.4.8.1
RISING HEALTHCARE INVESTMENTS TO ACCELERATE GROWTH
10.4.9.1
INCREASING FOCUS ON EARLY DETECTION AND IMPROVING SURVIVAL RATES TO DRIVE MARKET
10.4.10
REST OF ASIA PACIFIC
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2
LATIN AMERICA: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
10.5.3.1
INCREASING DEMAND FOR PRECISION MEDICINE AND ADVANCEMENTS IN GENOMICS TO FOSTER GROWTH
10.5.4.1
RISING PREVALENCE OF CHRONIC AND INFECTIOUS CONDITIONS TO CONTRIBUTE TO GROWTH
10.5.5
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2
MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
10.6.3.1
KINGDOM OF SAUDI ARABIA (KSA)
10.6.3.2
UNITED ARAB EMIRATES (UAE)
10.6.3.3
REST OF GCC COUNTRIES
10.6.4
REST OF MIDDLE EAST & AFRICA
11
COMPETITIVE LANDSCAPE
Unveil market dominators and emerging disruptors shaping competitive dynamics and future growth.
300
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
11.3
REVENUE SHARE ANALYSIS, 2020–2024
11.4
MARKET SHARE ANALYSIS, 2024
11.4.1
GLOBAL MARKET SHARE ANALYSIS, 2024
11.4.2
US MARKET SHARE ANALYSIS, 2024
11.5
COMPANY VALUATION AND FINANCIAL METRICS
11.6
BRAND/PRODUCT COMPARATIVE ANALYSIS
11.7
R&D EXPENDITURE OF KEY PLAYERS
11.8
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.8.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.8.5.1
COMPANY FOOTPRINT
11.8.5.2
REGION FOOTPRINT
11.8.5.3
PRODUCT & SERVICE FOOTPRINT
11.8.5.5
FABRICATION TECHNOLOGY FOOTPRINT
11.9
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.9.1
PROGRESSIVE COMPANIES
11.9.2
RESPONSIVE COMPANIES
11.9.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.9.5.1
DETAILED LIST OF KEY STARTUPS/SMES
11.9.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.10
COMPETITIVE SCENARIO
11.10.1
PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS
11.10.4
OTHER DEVELOPMENTS
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
324
12.1.1
THERMO FISHER SCIENTIFIC INC.
12.1.1.1
BUSINESS OVERVIEW
12.1.1.2
PRODUCTS/SERVICES OFFERED
12.1.1.3
RECENT DEVELOPMENTS
12.1.3
AGILENT TECHNOLOGIES, INC.
12.1.4
F. HOFFMANN-LA ROCHE LTD
12.1.6
BIO-RAD LABORATORIES, INC.
12.1.14
RANDOX LABORATORIES LTD.
12.1.15
OXFORD GENE TECHNOLOGY IP LIMITED
12.2.3
PHALANX BIOTECH GROUP
12.2.4
ARRAYIT CORPORATION
12.2.9
CAPITALBIOTECH CO., LTD.
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3
CUSTOMIZATION OPTIONS
13.3.2
COMPANY INFORMATION
13.3.3
GEOGRAPHIC ANALYSIS
13.3.4
REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
13.3.5
COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
13.3.6
BY PRODUCT MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
13.3.7
ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
TABLE 1
BIOCHIPS MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES, 2021–2024 (UNIT OF USD)
TABLE 3
BIOCHIPS MARKET: RISK ASSESSMENT
TABLE 4
BIOCHIPS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8
BIOCHIPS MARKET: MAJOR PATENTS, 2022–2025
TABLE 9
IMPORT DATA FOR HS CODE 9027, BY COUNTRY, 2020–2024 (USD THOUSANDS)
TABLE 10
EXPORT DATA FOR HS CODE 9027, BY COUNTRY, 2020–2024 (USD THOUSANDS)
TABLE 11
AVERAGE SELLING PRICE TREND OF BIOCHIPS, BY KEY PLAYER, 2022–2024
TABLE 12
AVERAGE SELLING PRICE TREND OF DNA CHIPS, BY REGION, 2022–2024
TABLE 13
AVERAGE SELLING PRICE TREND FOR LAB-ON-A-CHIP, BY REGION, 2022–2024
TABLE 14
AVERAGE SELLING PRICE TREND OF PROTEIN CHIPS, BY REGION, 2022–2024
TABLE 15
BIOCHIPS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
TABLE 16
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BIOCHIPS, BY PRODUCT
TABLE 17
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 18
KEY COMPANIES IMPLEMENTING AI IN BIOCHIPS MARKET
TABLE 19
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 20
KEY PRODUCT-RELATED TARIFF EFFECTIVE BIOCHIPS
TABLE 21
NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
TABLE 22
ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
TABLE 23
EUROPE: IMPACT ON GERMANY AND UK DUE TO THE US TARIFFS
TABLE 24
LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
TABLE 25
BIOCHIPS MARKET, BY PRODUCTS & SERVICES, 2023–2030 (USD MILLION)
TABLE 26
BIOCHIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 27
KEY PLAYERS PROVIDING BIOCHIP CONSUMABLES
TABLE 28
BIOCHIPS MARKET FOR CONSUMABLES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 29
KEY PLAYERS PROVIDING BIOCHIP INSTRUMENTS
TABLE 30
BIOCHIPS MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
KEY PLAYERS PROVIDING BIOCHIPS SOFTWARE & SERVICES
TABLE 32
BIOCHIPS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33
BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 34
DNA CHIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35
GLOBAL VOLUME ANALYSIS OF DNA CHIPS, 2023–2030 (THOUSAND UNITS)
TABLE 36
DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 37
KEY PLAYERS PROVIDING DNA CHIPS FOR GENE EXPRESSION
TABLE 38
DNA CHIPS MARKET FOR GENE EXPRESSION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39
KEY PLAYERS PROVIDING DNA CHIPS FOR SNP GENOTYPING
TABLE 40
DNA CHIPS MARKET FOR SNP GENOTYPING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
KEY PLAYERS PROVIDING DNA CHIPS FOR CANCER DIAGNOSTICS & TREATMENT
TABLE 42
DNA CHIPS MARKET FOR CANCER DIAGNOSTICS & TREATMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
KEY PLAYERS PROVIDING DNA CHIPS FOR GENOMICS
TABLE 44
DNA CHIPS MARKET FOR GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
DNA CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46
DNA CHIPS MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
DNA CHIPS MARKET FOR OTHER DNA CHIP APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
LAB-ON-A-CHIP MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49
GLOBAL VOLUME ANALYSIS OF LAB-ON-A-CHIP, 2023–2030 (THOUSAND UNITS)
TABLE 50
LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 51
KEY PLAYERS PROVIDING LAB-ON-A-CHIP FOR CLINICAL DIAGNOSTIC
TABLE 52
LAB-ON-A-CHIP MARKET FOR CLINICAL DIAGNOSTIC, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
KEY PLAYERS PROVIDING LAB-ON-A-CHIP FOR GENOMICS
TABLE 54
LAB-ON-A-CHIP MARKET FOR GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55
KEY PLAYERS PROVIDING LAB-ON-A-CHIP FOR IVD & POC
TABLE 56
LAB-ON-A-CHIP MARKET FOR IVD & POC, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
KEY PLAYERS PROVIDING LAB-ON-A-CHIP FOR PROTEOMICS
TABLE 58
LAB-ON-A-CHIP MARKET FOR PROTEOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59
LAB-ON-A-CHIP MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
LAB-ON-A-CHIP MARKET FOR OTHER LOAC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61
PROTEIN CHIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62
GLOBAL VOLUME ANALYSIS OF PROTEIN CHIPS, 2023–2030 (THOUSAND UNITS)
TABLE 63
PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 64
KEY PLAYERS PROVIDING PROTEIN CHIPS FOR PROTEOMICS
TABLE 65
PROTEIN CHIPS MARKET FOR PROTEOMICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66
KEY PLAYERS PROVIDING PROTEIN CHIPS FOR EXPRESSION PROFILING
TABLE 67
PROTEIN CHIPS MARKET FOR EXPRESSION PROFILING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68
KEY PLAYERS PROVIDING PROTEIN CHIPS FOR DIAGNOSTICS
TABLE 69
PROTEIN CHIPS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70
KEY PLAYERS PROVIDING PROTEIN CHIPS FOR HIGH-THROUGHPUT SCREENING
TABLE 71
PROTEIN CHIPS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
PROTEIN CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
PROTEIN CHIPS MARKET FOR OTHER PROTEIN CHIP APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 74
KEY PLAYERS PROVIDING TISSUE ARRAYS
TABLE 75
TISSUE ARRAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76
GLOBAL VOLUME ANALYSIS OF TISSUE ARRAYS, 2023–2030 (THOUSAND UNITS)
TABLE 77
KEY PLAYERS PROVIDING CELL ARRAYS
TABLE 78
BIOCHIPS MARKET FOR CELL ARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
GLOBAL VOLUME ANALYSIS OF CELL ARRAYS, 2023–2030 (THOUSAND UNITS)
TABLE 80
BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 81
KEY PLAYERS PROVIDING BIOCHIP MICROARRAYS
TABLE 82
BIOCHIPS MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
KEY PLAYERS PROVIDING MICROFLUIDICS
TABLE 84
BIOCHIPS MARKET FOR MICROFLUIDICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 86
BIOCHIPS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87
BIOCHIPS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88
BIOCHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89
BIOCHIPS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
BIOCHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91
BIOCHIPS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 92
NORTH AMERICA: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
TABLE 93
NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 94
NORTH AMERICA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 95
NORTH AMERICA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 96
NORTH AMERICA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 97
NORTH AMERICA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 98
NORTH AMERICA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 99
NORTH AMERICA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 100
NORTH AMERICA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 101
US: KEY MACROECONOMIC INDICATORS
TABLE 102
US: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 103
US: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 104
US: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 105
US: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 106
US: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 107
US: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 108
US: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 109
CANADA: KEY MACROECONOMIC INDICATORS
TABLE 110
CANADA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 111
CANADA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
CANADA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 113
CANADA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 114
CANADA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 115
CANADA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 116
CANADA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 117
EUROPE: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
TABLE 118
EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119
EUROPE: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 120
EUROPE: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
EUROPE: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 122
EUROPE: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 123
EUROPE: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 124
EUROPE: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 125
EUROPE: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 126
GERMANY: KEY MACROECONOMIC INDICATORS
TABLE 127
GERMANY: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 128
GERMANY: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 129
GERMANY: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 130
GERMANY: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 131
GERMANY: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 132
GERMANY: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 133
GERMANY: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 134
UK: KEY MACROECONOMIC INDICATORS
TABLE 135
UK: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 136
UK: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137
UK: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 138
UK: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 139
UK: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 140
UK: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 141
UK: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 142
FRANCE: KEY MACROECONOMIC INDICATORS
TABLE 143
FRANCE: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 144
FRANCE: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 145
FRANCE: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 146
FRANCE: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 147
FRANCE: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 148
FRANCE: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 149
FRANCE: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 150
ITALY: KEY MACROECONOMIC INDICATORS
TABLE 151
ITALY: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 152
ITALY: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153
ITALY: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 154
ITALY: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 155
ITALY: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 156
ITALY: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 157
ITALY: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 158
SPAIN: KEY MACROECONOMIC INDICATORS
TABLE 159
SPAIN: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 160
SPAIN: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
SPAIN: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 162
SPAIN: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 163
SPAIN: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 164
SPAIN: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 165
SPAIN: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 166
NETHERLANDS: KEY MACROECONOMIC INDICATORS
TABLE 167
NETHERLANDS: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 168
NETHERLANDS: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
NETHERLANDS: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 170
NETHERLANDS: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 171
NETHERLANDS: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 172
NETHERLANDS: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 173
NETHERLANDS: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 174
REST OF EUROPE: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 175
REST OF EUROPE: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
REST OF EUROPE: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 177
REST OF EUROPE: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 178
REST OF EUROPE: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 179
REST OF EUROPE: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 180
REST OF EUROPE: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 181
ASIA PACIFIC: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
TABLE 182
ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 183
ASIA PACIFIC: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 184
ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 185
ASIA PACIFIC: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 186
ASIA PACIFIC: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 187
ASIA PACIFIC: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 188
ASIA PACIFIC: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 189
ASIA PACIFIC: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 190
CHINA: KEY MACROECONOMIC INDICATORS
TABLE 191
CHINA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 192
CHINA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193
CHINA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 194
CHINA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 195
CHINA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 196
CHINA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 197
CHINA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 198
JAPAN: KEY MACROECONOMIC INDICATORS
TABLE 199
JAPAN: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 200
JAPAN: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201
JAPAN: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 202
JAPAN: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 203
JAPAN: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 204
JAPAN: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 205
JAPAN: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 206
INDIA: KEY MACROECONOMIC INDICATORS
TABLE 207
INDIA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 208
INDIA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 209
INDIA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 210
INDIA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 211
INDIA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 212
INDIA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 213
INDIA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 214
AUSTRALIA: KEY MACROECONOMIC INDICATORS
TABLE 215
AUSTRALIA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 216
AUSTRALIA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
AUSTRALIA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 218
AUSTRALIA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 219
AUSTRALIA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 220
AUSTRALIA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 221
AUSTRALIA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 222
SOUTH KOREA: KEY MACROECONOMIC INDICATORS
TABLE 223
SOUTH KOREA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 224
SOUTH KOREA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
SOUTH KOREA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 226
SOUTH KOREA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 227
SOUTH KOREA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 228
SOUTH KOREA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 229
SOUTH KOREA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 230
THAILAND: KEY MACROECONOMIC INDICATORS
TABLE 231
THAILAND: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 232
THAILAND: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233
THAILAND: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 234
THAILAND: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 235
THAILAND: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 236
THAILAND: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 237
THAILAND: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 238
NEW ZEALAND: KEY MACROECONOMIC INDICATORS
TABLE 239
NEW ZEALAND: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 240
NEW ZEALAND: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
NEW ZEALAND: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 242
NEW ZEALAND: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 243
NEW ZEALAND: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 244
NEW ZEALAND: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 245
NEW ZEALAND: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 246
REST OF ASIA PACIFIC: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 247
REST OF ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248
REST OF ASIA PACIFIC: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 249
REST OF ASIA PACIFIC: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 250
REST OF ASIA PACIFIC: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 251
REST OF ASIA PACIFIC: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 252
REST OF ASIA PACIFIC: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 253
LATIN AMERICA: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
TABLE 254
LATIN AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 255
LATIN AMERICA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 256
LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257
LATIN AMERICA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 258
LATIN AMERICA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 259
LATIN AMERICA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 260
LATIN AMERICA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 261
LATIN AMERICA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 262
BRAZIL: KEY MACROECONOMIC INDICATORS
TABLE 263
BRAZIL: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 264
BRAZIL: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265
BRAZIL: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 266
BRAZIL: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 267
BRAZIL: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 268
BRAZIL: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 269
BRAZIL: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 270
MEXICO: KEY MACROECONOMIC INDICATORS
TABLE 271
MEXICO: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 272
MEXICO: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273
MEXICO: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 274
MEXICO: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 275
MEXICO: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 276
MEXICO: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 277
MEXICO: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 278
REST OF LATIN AMERICA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 279
REST OF LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280
REST OF LATIN AMERICA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 281
REST OF LATIN AMERICA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 282
REST OF LATIN AMERICA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 283
REST OF LATIN AMERICA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 284
REST OF LATIN AMERICA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 285
MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY TYPE, 2023–2030 (THOUSAND UNITS)
TABLE 286
MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 287
MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 288
MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289
MIDDLE EAST & AFRICA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 290
MIDDLE EAST & AFRICA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 291
MIDDLE EAST & AFRICA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 292
MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 293
MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 294
GCC COUNTRIES: BIOCHIPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 295
GCC COUNTRIES: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 296
GCC COUNTRIES: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 297
GCC COUNTRIES: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 298
GCC COUNTRIES: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 299
GCC COUNTRIES: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 300
GCC COUNTRIES: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 301
GCC COUNTRIES: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 302
KINGDOM OF SAUDI ARABIA (KSA): KEY MACROECONOMIC INDICATORS
TABLE 303
KINGDOM OF SAUDI ARABIA (KSA): BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 304
KINGDOM OF SAUDI ARABIA (KSA): BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305
KINGDOM OF SAUDI ARABIA (KSA): DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 306
KINGDOM OF SAUDI ARABIA (KSA): LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 307
KINGDOM OF SAUDI ARABIA (KSA): PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 308
KINGDOM OF SAUDI ARABIA (KSA): BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 309
KINGDOM OF SAUDI ARABIA (KSA): BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 310
UNITED ARAB EMIRATES (UAE): KEY MACROECONOMIC INDICATORS
TABLE 311
UNITED ARAB EMIRATES (UAE): BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 312
UNITED ARAB EMIRATES (UAE): BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 313
UNITED ARAB EMIRATES (UAE): DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 314
UNITED ARAB EMIRATES (UAE): LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 315
UNITED ARAB EMIRATES (UAE): PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 316
UNITED ARAB EMIRATES (UAE): BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 317
UNITED ARAB EMIRATES (UAE): BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 318
REST OF GCC COUNTRIES: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 319
REST OF GCC COUNTRIES: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320
REST OF GCC COUNTRIES: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 321
REST OF GCC COUNTRIES: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 322
REST OF GCC COUNTRIES: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 323
REST OF GCC COUNTRIES: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 324
REST OF GCC COUNTRIES: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 325
REST OF MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 326
REST OF MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 327
REST OF MIDDLE EAST & AFRICA: DNA CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 328
REST OF MIDDLE EAST & AFRICA: LAB-ON-A-CHIP MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 329
REST OF MIDDLE EAST & AFRICA: PROTEIN CHIPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 330
REST OF MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 331
REST OF MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 332
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOCHIPS MARKET, 2022–2024
TABLE 333
GLOBAL BIOCHIPS MARKET: DEGREE OF COMPETITION
TABLE 334
US BIOCHIPS MARKET: DEGREE OF COMPETITION
TABLE 335
BIOCHIPS MARKET: REGION FOOTPRINT
TABLE 336
BIOCHIPS MARKET: PRODUCT & SERVICE FOOTPRINT
TABLE 337
BIOCHIPS MARKET: TYPE FOOTPRINT
TABLE 338
BIOCHIPS MARKET: FABRICATION TECHNOLOGY FOOTPRINT
TABLE 339
BIOCHIPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 340
BIOCHIPS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 341
BIOCHIPS MARKET: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 342
BIOCHIPS MARKET: DEALS, JANUARY 2022−SEPTEMBER 2025
TABLE 343
BIOCHIPS MARKET: EXPANSIONS, JANUARY 2022−SEPTEMBER 2025
TABLE 344
BIOCHIPS MARKET: OTHERS, JANUARY 2022–SEPTEMBER 2025
TABLE 345
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 346
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 347
THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 348
ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 349
ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 350
ILLUMINA, INC.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 351
ILLUMINA, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 352
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 353
AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 354
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 355
AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 356
AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025
TABLE 357
F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW
TABLE 358
F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED
TABLE 359
F. HOFFMANN-LA ROCHE LTD: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 360
QIAGEN: COMPANY OVERVIEW
TABLE 361
QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 362
QIAGEN: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 363
QIAGEN: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 364
QIAGEN: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 365
QIAGEN: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025
TABLE 366
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 367
BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 368
ABBOTT: COMPANY OVERVIEW
TABLE 369
ABBOTT: PRODUCTS/SERVICES OFFERED
TABLE 370
ABBOTT: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 371
STANDARD BIOTOOLS: COMPANY OVERVIEW
TABLE 372
STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED
TABLE 373
STANDARD BIOTOOLS: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 374
STANDARD BIOTOOLS INC.: DEALS, JANUARY 2022−SEPTEMBER 2025
TABLE 375
STANDARD BIOTOOLS INC.: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025
TABLE 376
10X GENOMICS: COMPANY OVERVIEW
TABLE 377
10X GENOMICS: PRODUCTS/SERVICES OFFERED
TABLE 378
10X GENOMICS: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 379
10X GENOMICS: DEALS, JANUARY 2022−SEPTEMBER 2025
TABLE 380
10X GENOMICS: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025
TABLE 381
CEPHEID: COMPANY OVERVIEW
TABLE 382
CEPHEID: PRODUCTS/SERVICES OFFERED
TABLE 383
CEPHEID: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 384
CEPHEID: DEALS, JANUARY 2022−SEPTEMBER 2025
TABLE 385
CEPHEID: OTHER DEVELOPMENTS, JANUARY 2022−SEPTEMBER 2025
TABLE 386
BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 387
BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED
TABLE 388
BIOMÉRIEUX: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 389
BIOMÉRIEUX: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 390
REVVITY: COMPANY OVERVIEW
TABLE 391
REVVITY: PRODUCTS/SERVICES OFFERED
TABLE 392
REVVITY: DEALS, JANUARY 2022−SEPTEMBER 2025
TABLE 393
DIASORIN S.P.A.: COMPANY OVERVIEW
TABLE 394
DIASORIN S.P.A.: PRODUCTS/SERVICES OFFERED
TABLE 395
RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
TABLE 396
RANDOX LABORATORIES LTD.: PRODUCTS/SERVICES OFFERED
TABLE 397
RANDOX LABORATORIES LTD.: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2022−SEPTEMBER 2025
TABLE 398
RANDOX LABORATORIES LTD.: DEALS, JANUARY 2022−SEPTEMBER 2025
TABLE 399
RANDOX LABORATORIES LTD.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 400
OXFORD GENE TECHNOLOGY IP LIMITED: COMPANY OVERVIEW
TABLE 401
OXFORD GENE TECHNOLOGY IP LIMITED: PRODUCTS/SERVICES OFFERED
TABLE 402
MICRONIT B.V.: COMPANY OVERVIEW
TABLE 403
RAYBIOTECH, INC.: COMPANY OVERVIEW
TABLE 404
PHALANX BIOTECH GROUP: COMPANY OVERVIEW
TABLE 405
ARRAYIT CORPORATION: COMPANY OVERVIEW
TABLE 406
3DHISTECH LTD.: COMPANY OVERVIEW
TABLE 407
CREATIVE BIOARRAY: COMPANY OVERVIEW
TABLE 408
TISSUEARRAY.COM: COMPANY OVERVIEW
TABLE 409
IBIOCHIPS: COMPANY OVERVIEW
TABLE 410
CAPITALBIOTECH CO., LTD.: COMPANY OVERVIEW
TABLE 411
PEPPERPRINT GMBH: COMPANY OVERVIEW
FIGURE 1
BIOCHIPS MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 2
BIOCHIPS MARKET: RESEARCH DESIGN
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 7
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8
REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC INC.
FIGURE 9
REVENUE ANALYSIS OF TOP FIVE COMPANIES: BIOCHIPS MARKET (2024)
FIGURE 10
DEMAND-SIDE MARKET ESTIMATION FOR BIOCHIPS
FIGURE 11
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF BIOCHIPS MARKET (2025–2030)
FIGURE 12
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13
TOP-DOWN APPROACH
FIGURE 14
BOTTOM-UP APPROACH
FIGURE 15
MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 16
BIOCHIPS MARKET, BY PRODUCTS & SERVICES, 2025 VS. 2030 (USD MILLION)
FIGURE 17
BIOCHIPS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 18
DNA CHIPS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 19
LAB-ON-A-CHIP MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 20
PROTEIN CHIPS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 21
BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 22
BIOCHIPS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 23
GEOGRAPHIC SNAPSHOT OF BIOCHIPS MARKET
FIGURE 24
INCREASING INCIDENCE OF CHRONIC CONDITIONS TO FUEL MARKET
FIGURE 25
CONSUMABLES SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024
FIGURE 26
ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 27
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 28
EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 29
BIOCHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 30
BIOCHIPS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31
BIOCHIPS MARKET: PATENT ANALYSIS, JANUARY 2014–OCTOBER 2025
FIGURE 32
TOP APPLICANTS FOR BIOCHIPS PATENTS, BY JURISDICTION, JANUARY 2014–OCTOBER 2025
FIGURE 33
AVERAGE SELLING PRICE FOR DNA CHIPS AND LAB-ON-A-CHIP, BY KEY PLAYER, 2024
FIGURE 34
AVERAGE SELLING PRICE FOR DNA CHIPS AND LAB-ON-A-CHIP, BY REGION, 2024
FIGURE 35
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BIOCHIPS, BY PRODUCT
FIGURE 36
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 38
BIOCHIPS MARKET: ECOSYSTEM MARKET MAP
FIGURE 39
BIOCHIPS MARKET: VALUE CHAIN ANALYSIS
FIGURE 40
BIOCHIPS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 41
REVENUE SHIFT AND NEW REVENUE POCKETS FOR BIOCHIPS MARKET
FIGURE 42
BIOCHIPS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 43
NORTH AMERICA: BIOCHIPS MARKET SNAPSHOT
FIGURE 44
ASIA PACIFIC: BIOCHIPS MARKET SNAPSHOT
FIGURE 45
REVENUE ANALYSIS OF KEY PLAYERS IN BIOCHIPS MARKET, 2020−2024
FIGURE 46
MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOCHIPS MARKET, 2024
FIGURE 47
RANKING OF KEY PLAYERS IN BIOCHIPS MARKET, 2024
FIGURE 48
US: MARKET SHARE ANALYSIS OF KEY PLAYERS IN BIOCHIPS MARKET, 2024
FIGURE 49
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 50
EV/EBITDA OF KEY VENDORS
FIGURE 51
BIOCHIPS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 52
R&D EXPENDITURE OF KEY PLAYERS IN BIOCHIPS MARKET, 2022−2024
FIGURE 53
BIOCHIPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 54
BIOCHIPS MARKET: COMPANY FOOTPRINT
FIGURE 55
BIOCHIPS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 56
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 57
ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
FIGURE 58
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 59
F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2024)
FIGURE 60
QIAGEN: COMPANY SNAPSHOT (2024)
FIGURE 61
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 62
ABBOTT: COMPANY SNAPSHOT (2024)
FIGURE 63
STANDARD BIOTOOLS: COMPANY SNAPSHOT (2024)
FIGURE 64
10X GENOMICS: COMPANY SNAPSHOT (2024)
FIGURE 65
BIOMÉRIEUX: COMPANY SNAPSHOT (2024)
FIGURE 66
REVVITY: COMPANY SNAPSHOT (2024)
FIGURE 67
DIASORIN S.P.A.: COMPANY SNAPSHOT (2024)
Growth opportunities and latent adjacency in Biochips Market